어플

Hyundai Pharmaceutical's hair loss treatment 20,000 bottles are recalled

Business / 김지선 / 07/03/2023 05:10 AM

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hyundai Pharmaceutical is collecting the drug after it was reported that the hair loss treatment drug on sale is mixed with dementia treatment.

It is known that the products subject to recall are mixed with dementia treatments. This was revealed through a pharmacist's report. About 20,000 bottles of recalled products are said to have been produced.

The Ministry of Food and Drug Safety and Hyundai Pharmaceutical are announcing the recall of the product in question through the company's website. Separately, the Ministry of Food and Drug Safety is investigating how the incident occurred and whether consumers took it.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

NH Investment & Securities Cuts NAVER Target Price to KRW 320,000, Maintains ‘Buy’ on AI Growth Outlook
Korea’s Internet Banks Show Diverging Results as Platform Strategy Drives Performance Gap
South Korean Police Arrest Members of “Revenge-for-Hire” Ring Involved in Vandalism and Data Theft
KFTC Sanctions LS Affiliate Sunwoo for Improper Subcontract Documentation
FuriosaAI Secures Samsung SDS as New Client, to Deploy Renegade NPU in Servers Starting July
comments >

SNS